PCI – 7th June 2024
Thermofisher: Thu 29 February 2024, 11:15

Current Edition

Cell and Gene Therapy

Upcoming Events

SLAS Europe – 7th April 2025
PEGS Boston – 17/02/2025
Biotechnology Show 2025: 20th January 2025

Advertisement

Fujifilm rectangle: Fri 22 November 2024, 14:23
Roald Dahl Charity: Fri 15 November 2024, 12:57
A&M STABTEST: Fri 21 June 2024, 11:43
CDD Vault – 18.03.2025
Biopharma Group – 19th March 2025

Inhalation Advances

Respiratory diseases like asthma and chronic obstructive pulmonary disease (COPD) remain the third leading cause of death globally and are growing in prevalence throughout the world. According to the World Health Organization (WHO), COPD affects 251 million people and was the cause of death for 3.17 million people, reflecting 5% of all deaths worldwide. In their Millennium Development Goals (MDG), the WHO urges that through cooperation with pharmaceutical companies, developing countries can provide access to affordable, essential drugs. Frédérique Bordes-Picard and Sven Stegemann of Lonza Pharma and Biotech expand on this possibility.

[wonderplugin_pdf src=”https://www.biopharmaceuticalmedia.com/wp-content/uploads/2018/05/Inhalation-advances.pdf” width=”100%” height=”900px” style=”border:0;”]

Newcells 3 June 2024, 15:12
Aldevron: 16th January 2025
Richter: Wed 23 October 2024, 09:03
Tosoh – 29.04.25
Eppendorf – 18.03.2025
Asychem – 10.04.2025
Taconic Biosciences – 29.04.25
Steribar – 12.05.2025